Literature DB >> 18407786

Epigenetic interplay between histone modifications and DNA methylation in gene silencing.

Thomas Vaissière1, Carla Sawan, Zdenko Herceg.   

Abstract

Knowledge on heritable changes in gene expression that result from epigenetic events is of increasing relevance in the development of strategies for prevention, early diagnosis and treatment of cancer. Histone acetylation and DNA methylation are epigenetic modifications whose patterns can be regarded as heritable marks that ensure accurate transmission of the chromatin states and gene expression profiles over many cell generations. Importantly, patterns and levels of DNA methylation and histone acetylation are profoundly altered in human cancers. Accumulating evidence suggests that an epigenetic cross-talk, i.e. interplay between DNA methylation and histone acetylation, may be involved in the process of gene transcription and aberrant gene silencing in tumours. Although the molecular mechanism of gene activation is relatively well understood, the hierarchical order of events and dependencies leading to gene silencing in the course of cancer development remain largely unknown. While some studies suggest that DNA methylation patterns guide histone modifications (including histone acetylation and methylation) during gene silencing, other studies argue that DNA methylation takes its cues primarily from histone modification states. In this review, we summarize current knowledge on the interplay between DNA methylation and histone modifications during gene silencing and its importance in the integration of environmental and intrinsic stimuli in the control of gene expression. We also discuss the importance of an epigenetic cross-talk in the protection against genetic changes in response to environmental genotoxins as well as the implication for cancer therapy and prevention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18407786     DOI: 10.1016/j.mrrev.2008.02.004

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  222 in total

Review 1.  Epigenetic regulation in alcoholic liver disease.

Authors:  Pranoti Mandrekar
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  Environmental chemical exposures and human epigenetics.

Authors:  Lifang Hou; Xiao Zhang; Dong Wang; Andrea Baccarelli
Journal:  Int J Epidemiol       Date:  2011-12-13       Impact factor: 7.196

3.  Early demethylation of non-CpG, CpC-rich, elements in the myogenin 5'-flanking region: a priming effect on the spreading of active demethylation.

Authors:  Andrea Fuso; Giampiero Ferraguti; Francesco Grandoni; Raffaella Ruggeri; Sigfrido Scarpa; Roberto Strom; Marco Lucarelli
Journal:  Cell Cycle       Date:  2010-10-29       Impact factor: 4.534

4.  Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts.

Authors:  Yan Y Sanders; Trygve O Tollefsbol; Brian M Varisco; James S Hagood
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-19       Impact factor: 6.914

5.  The Ezh2 polycomb group protein drives an aggressive phenotype in melanoma cancer stem cells and is a target of diet derived sulforaphane.

Authors:  Matthew L Fisher; Gautam Adhikary; Dan Grun; David M Kaetzel; Richard L Eckert
Journal:  Mol Carcinog       Date:  2015-12-23       Impact factor: 4.784

Review 6.  Oxidative stress and diabetic complications.

Authors:  Ferdinando Giacco; Michael Brownlee
Journal:  Circ Res       Date:  2010-10-29       Impact factor: 17.367

Review 7.  Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.

Authors:  Mahmoud Alhosin; Tanveer Sharif; Marc Mousli; Nelly Etienne-Selloum; Guy Fuhrmann; Valérie B Schini-Kerth; Christian Bronner
Journal:  J Exp Clin Cancer Res       Date:  2011-04-15

8.  CB1-receptor knockout neonatal mice are protected against ethanol-induced impairments of DNMT1, DNMT3A, and DNA methylation.

Authors:  Nagaraja N Nagre; Shivakumar Subbanna; Madhu Shivakumar; Delphine Psychoyos; Balapal S Basavarajappa
Journal:  J Neurochem       Date:  2015-01-27       Impact factor: 5.372

9.  The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.

Authors:  Sivaprakasam Balasubramanian; Gautam Adhikary; Richard L Eckert
Journal:  Carcinogenesis       Date:  2009-12-16       Impact factor: 4.944

10.  Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation.

Authors:  Qing Zhong; Renu A Kowluru
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-14       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.